Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Intra-Cellular Therapies, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 283
- +12 vs. Q3 2022
- Shares held
- 83.3M
- −178.1K (−0.2%) vs. Q3 2022
- Total value
- $4.41B
- +$523.2M (+13.5%) vs. Q3 2022
- New holders
- 48
- 95 more added
- Sold out
- 36
- 93 more reduced
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $2.54K |
| Q1 2026 | 1 | $2.54K |
| Q4 2025 | 1 | $2.54K |
| Q3 2025 | 1 | $2.54K |
| Q2 2025 | 4 | $4.15M |
| Q1 2025 | 395 | $13.6B |
| Q4 2024 | 387 | $8.08B |
| Q3 2024 | 356 | $7.12B |
| Q2 2024 | 376 | $6.62B |
| Q1 2024 | 346 | $6.15B |
| Q4 2023 | 335 | $6.42B |
| Q3 2023 | 294 | $4.54B |
| Q2 2023 | 288 | $5.34B |
| Q1 2023 | 274 | $4.55B |
| Q4 2022 | 283 | $4.41B |
| Q3 2022 | 274 | $3.89B |
| Q2 2022 | 266 | $4.65B |
| Q1 2022 | 241 | $4.94B |
| Q4 2021 | 208 | $3.60B |
| Q3 2021 | 181 | $2.56B |
| Q2 2021 | 187 | $2.74B |
| Q1 2021 | 170 | $2.30B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −10,279−100.0% | Sold out |
| Illinois Municipal Retirement Fund | 0 | $0 | 0.00% | −10,091−100.0% | Sold out |
| SeaCrest Wealth Management, LLC | 0 | $0 | 0.00% | −9,090−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −8,357−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −7,900−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −6,701−100.0% | Sold out |
| Cipher Capital LP | 0 | $0 | 0.00% | −5,308−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −4,982−100.0% | Sold out |
| Raymond James Trust N.A. | 0 | $0 | 0.00% | −4,467−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,189−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −401−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| MUFG Americas Holdings Corp | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −2,788−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |